Effects of beta-glucans ingestion (Saccharomyces cerevisiae) on metabolism of rats receiving high-fat diet

Journal of Animal Physiology and Animal Nutrition

Volumn 101, Issue 2, 2017, Pages 349-358

  de Araujo T V ^a   Andrade, E F ^a   Lobato, R V ^a   Orlando, D R ^b   Gomes, N F ^a   de Sousa, R V ^a   Zangeronimo, M G ^a   Pereira, L J ^a  

^a FEDERAL UNIVERSITY OF LAVRAS   (Brazil)

^b UNIVERSIDADE FEDERAL DOS VALES DO JEQUITINHONHA E MUCURI   (Brazil)

Author keywords

beta glucan; diet; fibre; functional food; metabolism; obesity

Indexed keywords

BETA GLUCAN; FAT INTAKE;

ANIMAL; ANIMAL FOOD; FAT INTAKE; LIPID DIET; MALE; METABOLISM; OBESITY; RANDOMIZATION; RAT; SACCHAROMYCES CEREVISIAE;

ANIMAL FEED; ANIMALS; BETA-GLUCANS; DIET, HIGH-FAT; DIETARY FATS; MALE; OBESITY; RANDOM ALLOCATION; RATS; SACCHAROMYCES CEREVISIAE;

EID: 84961267223     PISSN: 09312439     EISSN: 14390396     Source Type: Journal    
DOI: 10.1111/jpn.12452     Document Type: Article

References (50)

1. Adibmoradi, M.; Navidshad, B.; Seifdavati, J.; Royan, M., 2006: Effect of dietary Garlic meal on histological structure of small intestine in broiler chickens. The Journal of Poultry Science 43, 378–383.
2. Amr, A. R.; Abeer, E. E. K., 2011: Hypolipideimic and hypocholestermic effect of pine nuts in rats fed high fat, cholesterol-diet. World Applied Sciences Journal 15, 1667–1677.
3. Andrade, E. F.; Lobato, R. V.; Araújo, T. V.; Orlando, D. R.; Gomes, N. F.; Alvarenga, R. R.; Rogatto, G. P.; Zangeronimo, M. G.; Pereira, L. J., 2014: Metabolic effects of glycerol supplementation and aerobic physical training on Wistar rats. Canadian Journal of Physiology and Pharmacology 92, 744–751.
4. AOAC (Association of Official Analytical Chemistry), 2000: Official Methods of Analysis 17th edn. Association of Official Analytical Chemists, Inc.,Washington D. C., p. 2000.
5. Battilana, P.; Ornstein, K.; Minehira, K.; Schwarz, J. M.; Acheson, K.; Schneiter, P.; Burri, J.; Jéquier, E.; Tappy, L., 2001: Mechanisms of action of beta-glucan in postprandial glucose metabolism in healthy men. European Journal of Clinical Nutrition 55, 327–333.
6. Bernardis, L. L.; Patterson, B. D., 1968: Correlation between “Lee index” and carcass fat content in weanling and adult female rats with hypothalamic lesions. The Journal of Endocrinology 40, 527–528.
7. Cavallero, A.; Empilli, S.; Brighenti, F.; Stanca, A. M., 2002: High (1→3,1→4)-β-glucan barley fractions in bread making and their effects on human glycemic response. Journal of Cereal Science 36, 59–66.
8. Chang, H. C.; Huang, C. N.; Yeh, D. M.; Wang, S. J.; Peng, C. H.; Wang, C. J., 2013: Oat prevents obesity and abdominal fat distribution, and improves liver function in humans. Plant Foods for Human Nutrition (Dordrecht, Netherlands) 68, 18–23.
9. Chen, J.; Zhang, X. D.; Jiang, Z., 2013: The application of fungal β-glucans for the treatment of colon cancer. Anti-cancer Agents in Medicinal Chemistry 13, 725–730.
10. Chu, H. F.; Pan, M. H.; Ho, C. T.; Tseng, Y. H.; Wang, W. W. L.; Chau, C. F., 2014: Variations in the efficacy of resistant maltodextrin on body fat reduction in rats fed different high-fat models. Journal of Agricultural and Food Chemistry 62, 192–197.
11. De Paula, A. C. C. F. F.; Sousa, R. V.; Figueiredo-Ribeiro, R. C. L.; Buckeridge, M. S., 2005: Hypoglycemic activity of polysaccharide fractions containing beta-glucans from extracts of Rhynchelytrum repens (Willd.) C.E. Hubb., Poaceae. Brazilian Journal of Medical and Biological Research 38, 885–893.
12. Do Nascimento, C. M.; Cassol, T.; da Silva, F. S.; Bonfleur, M. L.; Nassar, C. A.; Nassar, P. O., 2013: Radiographic evaluation of the effect of obesity on alveolar bone in rats with ligature-induced periodontal disease. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 6, 365–370.
13. Domènech, A.; Pasquinelli, G.; De Giorgio, R.; Gori, A.; Bosch, F.; Pumarola, M.; Jiménez, M., 2011: Morphofunctional changes underlying intestinal dysmotility in diabetic RIP-I/hIFNβ transgenic mice. International Journal of Experimental Pathology 92, 400–412.
14. Fernandes-Santos, C.; Carneiro, R. E.; de Souza Mendonca, L.; Aguila, M. B.; Mandarim-de-Lacerda, C. A., 2009: Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet. Nutrition (Burbank) 25, 818–827.
15. Fitzgerald, S. M.; Henegar, J. R.; Brands, M. W.; Henegar, L. K.; Hall, J. E., 2001: Cardiovascular and renal responses to a high-fat diet in Osborne-Mendel rats. American Journal of Physiology 281, R547–R552.
16. Francelino Andrade, E.; Vieira Lobato, R.; Vasques Araújo, T.; Gilberto Zangerônimo, M.; Vicente Sousa, R.; José Pereira, L., 2014: Effect of beta-glucans in the control of blood glucose levels of diabetic patients: a systematic review. Nutricion Hospitalaria 31, 170–177.
17. Gao, R.; Wang, Y.; Wu, Z.; Ming, J.; Zhao, G., 2012: Interaction of barley β-glucan and tea polyphenols on glucose metabolism in streptozotocin-induced diabetic rats. Journal of Food Science 77, 128–134.
18. Gauthier, M. S.; Couturier, K.; Latour, J. G.; Lavoie, J. M., 2003: Concurrent exercise prevents high-fat-diet-induced macrovesicular hepatic steatosis. Journal of Applied Physiology (Bethesda) 94, 2127–2134.
19. Guillaume-Gentil, C.; Rohner-Jeanrenaud, F.; Abramo, F.; Bestetti, G. E.; Rossi, G. L.; Jeanrenaud, B., 1990: Abnormal regulation of the hypothalamo-pituitary-adrenal axis in the genetically obese fa/fa rat. Endocrinology 126, 1873–1879.
20. Gunness, P.; Gidley, M. J., 2010: Mechanisms underlying the cholesterol-lowering properties of soluble dietary fibre polysaccharides. Food & Function 1, 149–155.
21. Harnack, U.; Eckert, K.; Pecher, G., 2011: Beta-(1–3), (1–6)-D-glucan enhances the effect of low-dose cyclophosphamide treatment on A20 lymphoma in mice. Anticancer Research 31, 1169–1172.
22. Jiang, T.; Wang, Z.; Proctor, G.; Moskowitz, S.; Liebman, S. E.; Rogers, T.; Lucia, M. S.; Li, J.; Levi, M., 2005: Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. The Journal of Biological Chemistry 280, 32317–32325.
23. King, D. E.; Mainous, A. G.; Egan, B. M.; Woolson, R. F.; Geesey, M. E., 2005: Fiber and C-reactive protein in diabetes, hypertension, and obesity. Diabetes Care 28, 1487–1489.
24. Lo, H. C.; Tu, S. T.; Lin, K. C.; Lin, S. C., 2004: The anti-hyperglycemic activity of the fruiting body of Cordyceps in diabetic rats induced by nicotinamide and streptozotocin. Life Sciences 74, 2897–2908.
25. Luo, Y.; Ma, X.; Shen, Y.; Hao, Y.; Hu, Y.; Xiao, Y.; Bao, Y.; Jia, W., 2014: Positive relationship between serum low-density lipoprotein cholesterol levels and visceral fat in a Chinese nondiabetic population. PLoS One 9, e112715.
26. Luppi, M.; Cerri, M.; Martelli, D.; Tupone, D.; Del Vecchio, F.; Di Cristoforo, A.; Perez, E.; Zamboni, G.; Amici, R., 2014: Waking and sleeping in the rat made obese through a high-fat hypercaloric diet. Behavioural Brain Research 258, 145–152.
27. Magliano, D. C.; Bargut, T. C. L.; de Carvalho, S. N.; Aguila, M. B.; Mandarim-de-Lacerda, C. A.; Souza-Mello, V., 2013: Peroxisome proliferator-activated receptors-alpha and gamma are targets to treat offspring from maternal diet-induced obesity in mice. PLoS One 8, e64258.
28. Mantovani, M. S.; Bellini, M. F.; Angeli, J. P. F.; Oliveira, R. J.; Silva, A. F.; Ribeiro, L. R., 2008: Beta-Glucans in promoting health: prevention against mutation and cancer. Mutation Research 658, 154–161.
29. Martinez-Flores, H. E.; Kil Chang, Y.; Martinez-Bustos, F.; Sgarbieri, V., 2004: Effect of high fiber products on blood lipids and lipoproteins in hamsters. Nutrition Research 24, 85–93.
30. Messora, M. R.; Oliveira, L. F. F.; Foureaux, R. C.; Taba, M.; Zangerônimo, M. G.; Furlaneto, F. A.; Pereira, L. J., 2013: Probiotic therapy reduces periodontal tissue destruction and improves the intestinal morphology in rats with ligature-induced periodontitis. Journal of Periodontology 84, 1818–1826.
31. Mohamed, M. M., 2011: Effects of chitosan and wheat bran on serum leptin, tnf-α, lipid profile and oxidative status in animal model of non-alc oholic fatty liver. Australian Journal of Basic and Applied Sciences 5, 1478–1488.
32. Nascimento, R. C.; Mabel, H.; Queiroz, B. N.; Paresque, R., 2013: Gastrointestinal morphological alterations in obese rats kept under hypercaloric diets. International Journal of General Medicine 6, 479–488.
33. Page, K. A.; Hartzell, D. L.; Li, C.; Westby, A. L.; Della-Fera, M. A.; Azain, M. J.; Pringle, T. D.; Baile, C. A., 2004: β-Adrenergic receptor agonists increase apoptosis of adipose tissue in mice. Domestic Animal Endocrinology 26, 23–31.
34. Popkin, B. M.; D'Anci, K. E.; Rosenberg, I. H., 2010: Water, hydration, and health. Nutrition Reviews 68, 439–458.
35. Popkin, B. M.; Adair, L. S.; Ng, S. W., 2012: Global nutrition transition and the pandemic of obesity in developing countries. Nutrition Reviews 70, 3–21.
36. Queenan, K. M.; Stewart, M. L.; Smith, K. N.; Thomas, W.; Fulcher, R. G.; Slavin, J. L., 2007: Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutrition Journal 6.
37. Reeves, P. G.; Nielsen, F. H.; Fahey, G. C., 1993: AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. The Journal of Nutrition 123, 1939–1951.
38. Reyna, N. Y.; Cano, C.; Bermúdez, V. J.; Medina, M. T.; Souki, A. J.; Ambard, M.; Nuñez, M.; Ferrer, M. A.; Inglett, G. E., 2003: Sweeteners and beta-glucans improve metabolic and anthropometrics variables in well controlled type 2 diabetic patients. American Journal of Therapeutics 10, 438–443.
39. Rutters, F.; Nieuwenhuizen, A. G.; Lemmens, S. G. T.; Born, J. M.; Westerterp-Plantenga, M. S., 2010: Hypothalamic-pituitary-adrenal (HPA) axis functioning in relation to body fat distribution. Clinical Endocrinology 72, 738–743.
40. SAS (SAS Institute, Inc.), 2006: Base SAS 9.1.3 Procedures Guide2nd edn. SAS Institute Inc., Cary, Ind.
41. Sasidharan, S. R.; Joseph, J. A.; Anandakumar, S.; Venkatesan, V.; Ariyattu Madhavan, C. N.; Agarwal, A., 2013: An experimental approach for selecting appropriate rodent diets for research studies on metabolic disorders. BioMed Research International 2013, 752870.
42. Schipper, H. S.; Prakken, B.; Kalkhoven, E.; Boes, M., 2012: Adipose tissue-resident immune cells: key players in immunometabolism. Trends in Endocrinology and Metabolism 23, 407–415.
43. Silva, V. O.; Lobato, R. V.; Andrade, E. F.; de Macedo, C. G.; Napimoga, J. T.; Napimoga, M. H.; Messora, M. R.; Murata, R. M.; Pereira, L. J., 2015: β-Glucans (Saccharomyces cereviseae) Reduce Glucose Levels and Attenuate Alveolar Bone Loss in Diabetic Rats with Periodontal Disease. PLoS One 10, e0134742.
44. Staels, B.; Fruchart, J. C., 2005: Therapeutic roles of peroxisome proliferator-activated receptor agonists. Diabetes 54, 2460–2470.
45. Statistics National Center for Health (US), 2014: Health, United States, 2013: With Special Feature on Prescription Drugs.
46. Strain, G. W.; Zumoff, B.; Strain, J. J.; Levin, J.; Fukushima, D. K., 1980: Cortisol production in obesity. Metabolism: Clinical and Experimental 29, 980–985.
47. Velasco, M. V.; Tano, C. T.; Machado-Santelli, G. M.; Consiglieri, V. O.; Kaneko, T. M.; Baby, A. R., 2008: Effects of caffeine and siloxanetriol alginate caffeine, as anticellulite agents, on fatty tissue: histological evaluation. Journal of Cosmetic Dermatology 7, 23–29.
48. Vieira Lobato, R.; De Oliveira Silva, V.; Francelino Andrade, E.; Ribeiro Orlando, D.; Gilberto Zangeronimo, M.; Vicente de Sousa, R.; José Pereira, L., 2015: Metabolic Effects of β-glucans (Saccharomyces cerevisae) per os Administration in Rats with Streptozotocin-induced Diabetes. Nutriciòn Hospitalaria 32, 256–264.
49. Viuda-Martos, M.; López-Marcos, M. C.; Fernández-López, J.; Sendra, E.; López-Vargas, J. H.; Pérez-Álvarez, J. A., 2010: Role of fiber in cardiovascular diseases: a review. Comprehensive Reviews in Food Science and Food Safety 9, 240–258.
50. Who, W. H. O., 2000: Obesity: Preventing and Managing the Global Epidemic. Switzerland, Geneva, p. 894.